Technical Articles

The KRAS gene is one of the most frequently mutated oncogenes in human cancers, appearing at high frequencies in pancreatic, colorectal, and lung cancers. As a central regulator of cellular signaling pathways, the KRAS protein functions like a molecular switch to control cell division and quiescence.

The KRAS gene is one of the most frequently mutated oncogenes in human malignancies, with this mutation detected in approximately one in seven cancers.

The KRAS gene is one of the most common oncogenes in human cancers, frequently mutated in various solid tumors such as pancreatic cancer, colorectal cancer, and lung cancer.

The KRAS gene is one of the most frequently mutated oncogenes in human malignancies, with approximately 30% of high-mortality tumors associated with KRAS mutations.

The KRAS gene is one of the most commonly mutated oncogenes in human cancers and is frequently found in various malignancies such as pancreatic cancer, colorectal cancer, and lung cancer.

Pancreatic ductal adenocarcinoma, known as the "king of cancers," is notorious for its high malignancy and extremely poor prognosis. The KRAS gene mutation occurs in up to 93% of pancreatic cancer cases, with KRAS G12D being the most common mutation subtype.